Geron reported $126.6M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Amgen USD 6.39B 169M Sep/2026
Bio Techne USD 197.67M 1.92M Sep/2026
Cytokinetics USD 807K 427K Sep/2026
Exelixis USD 29.87M 1.14M Sep/2026
Genmab DKK 21M 8M Mar/2026
Geron USD 126.6M 3M Sep/2026
Gilead Sciences USD 1.9B 57M Sep/2026
Incyte USD 134.25M 21.71M Sep/2026
MacroGenics USD 9.5M 1.59M Mar/2026
Novartis USD 6.1B 116M Sep/2026
Novavax USD 18.5M 8.49M Sep/2026